Nutex Health Inc. (NUTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 300M 600M 900M FY10: 874.8K FY11: 1.8M FY12: 1.6M FY13: 1.5M FY14: 1.1M FY15: 474.7K FY16: 0 FY17: 23.2K FY18: 1.4M FY19: 1.4M FY20: 274M FY21: 331.5M FY22: 219.3M FY23: 247.6M FY24: 479.9M FY25: 875.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-200M 0 200M 400M 600M FY10: 483.2K FY11: 1M FY12: 810.4K FY13: 965.2K FY14: 603.3K FY15: 466.6K FY16: 0 FY17: -7.3K FY18: 859.4K FY19: 536K FY20: 157.6M FY21: 179.3M FY22: 15.4M FY23: 34.8M FY24: 196.3M FY25: 444.3M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

-450M -300M -150M 0 150M 300M 450M FY10: -1.3M FY11: -844.6K FY12: -1.6M FY13: -727.4K FY14: -723.4K FY15: -533K FY16: -448.6K FY17: -5.7M FY18: -840.4K FY19: -6.9M FY20: 153.2M FY21: 170.3M FY22: -406.6M FY23: -31.8M FY24: 130.7M FY25: 275.6M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-450M -300M -150M 0 150M 300M 450M FY10: 158.1K FY11: -383.4K FY12: -1.6M FY13: 250.5K FY14: -684.3K FY15: 83.8K FY16: -7.4M FY17: 582.1K FY18: -950.1K FY19: -7.1M FY20: 106M FY21: 132.6M FY22: -424.8M FY23: -45.8M FY24: 52.1M FY25: 70.8M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 5M 10M 15M FY10: 391.6K FY11: 764.7K FY12: 783.5K FY13: 496K FY14: 465.3K FY15: 8.1K FY16: 0 FY17: 30.5K FY18: 507.6K FY19: 830.4K FY20: 909.8K FY21: 14.6M FY11 FY13 FY15 FY17 FY19 FY21

Operating Cash Flow Annual

-90M 0 90M 180M 270M FY10: -1.6M FY11: -659.1K FY12: -518.7K FY13: -183.2K FY14: 159.2K FY15: 44.9K FY16: -274.2K FY17: -714.6K FY18: -480K FY19: -4M FY20: 86.7M FY21: 173.4M FY22: 50.6M FY23: 1.3M FY24: 23.2M FY25: 248.1M FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-90M 0 90M 180M 270M FY10: -1.6M FY11: -678.5K FY12: -526.7K FY14: 157.2K FY15: 43.1K FY18: -480K FY19: -4.1M FY20: 25.5M FY21: 136.5M FY22: 36M FY23: -8.2M FY24: 20.8M FY25: 245.6M FY10 FY12 FY15 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 250M 500M 750M FY12: 24M FY13: 26M FY14: 25.9M FY15: 29.2M FY16: 39.7M FY20: 592.8M FY21: 592.8M FY22: 4.2M FY23: 4.4M FY24: 5.5M FY25: 6.8M FY12 FY13 FY14 FY15 FY16 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -9.00 0.00 9.00 18.00 27.00 Q4 '11: -0.03 Q1 '12: -0.04 Q2 '12: -0.05 Q3 '12: -0.05 Q4 '12: -0.07 Q1 '13: -0.07 Q2 '13: -0.04 Q1 '15: -0.05 Q2 '15: -0.05 Q3 '15: -0.04 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: -0.19 Q1 '17: -0.18 Q2 '17: -0.21 Q3 '17: -0.15 Q4 '17: 0.01 Q1 '18: 0.00 Q2 '18: 0.02 Q3 '18: -2.13 Q4 '19: -1.97 Q1 '20: -1.83 Q2 '20: -1.34 Q3 '20: -0.78 Q4 '20: -1.17 Q1 '21: -1.17 Q2 '21: -1.17 Q3 '21: -1.42 Q4 '21: -0.08 Q1 '22: 0.20 Q2 '22: 0.12 Q3 '22: -0.59 Q4 '22: -0.63 Q1 '23: -0.79 Q2 '24: -8.87 Q3 '24: -9.34 Q4 '24: 9.25 Q1 '25: 12.66 Q2 '25: 9.78 Q3 '25: 19.26 Q4 '25: 9.75 Q1 '26: 12.94 Q2 '26: 25.27 Q2 '12 Q2 '15 Q4 '16 Q2 '18 Q4 '20 Q2 '22 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.